Cargando…

IL-1R8 as Pathoimmunological Marker for Severity of Canine Chronic Enteropathy

Chronic enteropathy (CE) is a severe multifactorial gastrointestinal disease that affects dogs and is driven by poorly characterized inflammatory pathways. Imbalance of pro-inflammatory response regulators, including IL-1R8, may be due to different factors, among which the infection with Helicobacte...

Descripción completa

Detalles Bibliográficos
Autores principales: Riva, Federica, Bianchessi, Laura, Recordati, Camilla, Inglesi, Alessia, Castiglioni, Vittoria, Turin, Lauretta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229266/
https://www.ncbi.nlm.nih.gov/pubmed/35737347
http://dx.doi.org/10.3390/vetsci9060295
_version_ 1784734699791319040
author Riva, Federica
Bianchessi, Laura
Recordati, Camilla
Inglesi, Alessia
Castiglioni, Vittoria
Turin, Lauretta
author_facet Riva, Federica
Bianchessi, Laura
Recordati, Camilla
Inglesi, Alessia
Castiglioni, Vittoria
Turin, Lauretta
author_sort Riva, Federica
collection PubMed
description Chronic enteropathy (CE) is a severe multifactorial gastrointestinal disease that affects dogs and is driven by poorly characterized inflammatory pathways. Imbalance of pro-inflammatory response regulators, including IL-1R8, may be due to different factors, among which the infection with Helicobacteraceae is known to lead to a vicious circle in which excessive pro-inflammatory signaling and gastrointestinal injury reinforce each other and boost the disease. We investigated the expression of IL-1R8 in large intestine biopsies of dogs with or without clinical signs of CE and with previously assessed enterohepatic Helicobacter spp. colonization status by mean of quantitative real-time PCR. Our study revealed that IL-1R8 is downregulated in both acutely (p = 0.0074) and chronically (p = 0.0159) CE affected dogs compared to healthy controls. The data also showed that IL-1R8 expression tends to decrease with colonization by Helicobacter spp. Interestingly, a negative correlation was detected between the level of expression of IL-1R8 and the severity of macroscopic lesions identified by endoscopy and the crypt hyperplasia score. We further compared the expression levels between males and females and found no statistically significant difference between the two groups. No significant difference was observed in IL-1R8 expression profiles with the age of the animals either. Interestingly, an association was uncovered between IL-1R8 expression level and dog breed. Together, our data advance knowledge on gastrointestinal pathoimmunology in dogs and highlight the potential utilization of IL-1R8 as a diagnostic, prognostic and therapeutic biomarker for canine chronic enteropathy.
format Online
Article
Text
id pubmed-9229266
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92292662022-06-25 IL-1R8 as Pathoimmunological Marker for Severity of Canine Chronic Enteropathy Riva, Federica Bianchessi, Laura Recordati, Camilla Inglesi, Alessia Castiglioni, Vittoria Turin, Lauretta Vet Sci Article Chronic enteropathy (CE) is a severe multifactorial gastrointestinal disease that affects dogs and is driven by poorly characterized inflammatory pathways. Imbalance of pro-inflammatory response regulators, including IL-1R8, may be due to different factors, among which the infection with Helicobacteraceae is known to lead to a vicious circle in which excessive pro-inflammatory signaling and gastrointestinal injury reinforce each other and boost the disease. We investigated the expression of IL-1R8 in large intestine biopsies of dogs with or without clinical signs of CE and with previously assessed enterohepatic Helicobacter spp. colonization status by mean of quantitative real-time PCR. Our study revealed that IL-1R8 is downregulated in both acutely (p = 0.0074) and chronically (p = 0.0159) CE affected dogs compared to healthy controls. The data also showed that IL-1R8 expression tends to decrease with colonization by Helicobacter spp. Interestingly, a negative correlation was detected between the level of expression of IL-1R8 and the severity of macroscopic lesions identified by endoscopy and the crypt hyperplasia score. We further compared the expression levels between males and females and found no statistically significant difference between the two groups. No significant difference was observed in IL-1R8 expression profiles with the age of the animals either. Interestingly, an association was uncovered between IL-1R8 expression level and dog breed. Together, our data advance knowledge on gastrointestinal pathoimmunology in dogs and highlight the potential utilization of IL-1R8 as a diagnostic, prognostic and therapeutic biomarker for canine chronic enteropathy. MDPI 2022-06-14 /pmc/articles/PMC9229266/ /pubmed/35737347 http://dx.doi.org/10.3390/vetsci9060295 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Riva, Federica
Bianchessi, Laura
Recordati, Camilla
Inglesi, Alessia
Castiglioni, Vittoria
Turin, Lauretta
IL-1R8 as Pathoimmunological Marker for Severity of Canine Chronic Enteropathy
title IL-1R8 as Pathoimmunological Marker for Severity of Canine Chronic Enteropathy
title_full IL-1R8 as Pathoimmunological Marker for Severity of Canine Chronic Enteropathy
title_fullStr IL-1R8 as Pathoimmunological Marker for Severity of Canine Chronic Enteropathy
title_full_unstemmed IL-1R8 as Pathoimmunological Marker for Severity of Canine Chronic Enteropathy
title_short IL-1R8 as Pathoimmunological Marker for Severity of Canine Chronic Enteropathy
title_sort il-1r8 as pathoimmunological marker for severity of canine chronic enteropathy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229266/
https://www.ncbi.nlm.nih.gov/pubmed/35737347
http://dx.doi.org/10.3390/vetsci9060295
work_keys_str_mv AT rivafederica il1r8aspathoimmunologicalmarkerforseverityofcaninechronicenteropathy
AT bianchessilaura il1r8aspathoimmunologicalmarkerforseverityofcaninechronicenteropathy
AT recordaticamilla il1r8aspathoimmunologicalmarkerforseverityofcaninechronicenteropathy
AT inglesialessia il1r8aspathoimmunologicalmarkerforseverityofcaninechronicenteropathy
AT castiglionivittoria il1r8aspathoimmunologicalmarkerforseverityofcaninechronicenteropathy
AT turinlauretta il1r8aspathoimmunologicalmarkerforseverityofcaninechronicenteropathy